A practical way to match short peptide bioregulators to the tissue you want to support,
and to tell certified products from the copies.
Most people arrive at peptide therapy the way they arrive at any supplement shelf: read a few reviews, pick the product with the loudest claims, hope for the best. Short peptides run on a different logic. Each one carries a signal addressed to a single tissue, and the address matters more than the dose.
Start with the tissue you want to support
Peptide bioregulators are short chains of amino acids, molecular weight up to 5000 Da, that your body makes on its own and makes less of with every decade. Work led by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology established the principle the whole category rests on: peptides act selectively on the cells of the tissue they came from. Thymus peptides speak to immune cells; vascular peptides, to the vessel wall.
That selectivity explains why the IPEPT peptide catalog is split across more than 20 health categories instead of one universal formula. Immunity, vessels, joints, liver, kidneys, thyroid, pancreas, lungs, eyes, brain, sleep, muscle recovery: each has its own bioregulator, because each tissue answers to its own peptide.
Someone hunting for a peptide for healing after a torn ligament needs a different address than someone working on sleep or vision. Naming your system comes first. Speed and form come after.
What separates cytomax peptides from cytogenes
Two lines of bioactive peptides cover most protocols. Cytomax products are natural peptides, extracted as low-molecular fractions from animal organ tissue. Cytogen products are synthesized from pure amino acids and reproduce the shortest working fragment of that same complex in one molecule.
| Attribute | Cytomax (natural) | Cytogen (synthesized) |
|---|---|---|
| Origin | extracted from animal organ tissue, native activity preserved | assembled from pure amino acids |
| Molecule | full peptide complex, up to 5000 Da | one short working fragment |
| Onset | gradual, cumulative | fast, inside the first course |
| Effect | prolonged, builds across months | activates early, tapers sooner |
| Course | up to 3 months, 1–2 times a year | 30–60 days, 2–3 times a year |
| Formats | capsules 20 / 60, lingual drops | capsules 20 / 60, lingual drops |
| Best placed | months two and three of a protocol | month one, or after illness and surgery |
People searching for the best category of peptides usually want one winner. The two lines were built to run in sequence, and natural peptides carry the heavier share of the work: a full fraction rather than a single fragment, structurally identical to what the tissue already recognizes. That is where Cytomax gets its depth and its staying power.
You can find out more by studying the article Cytogenes vs Cytomaxes:
https://www.ipept.com/cytomax_vs_cytogen_peptides
A four-step way to choose your peptide therapy
- Name the target tissue. Immune, vascular, musculoskeletal, digestive, respiratory, nervous, visual. Pick one priority instead of four.
- Decide how fast you need the response. Cytomax or Cytogen turns on this question: after infection, surgery, or a punishing training block, the synthesized line moves first.
- Pick the format. Capsules for a steady course; lingual drops when absorption speed carries weight.
- Book the window. Peptides are dosed in courses: 30 to 60 days for cytogenes, up to three months for cytomax peptides, then a gap of one or two months before the next one.
Standard dosing is unglamorous and worth following exactly. Cytogen capsules run one capsule twice a day with meals across a 30-day preventive course, moving to two capsules two or three times daily within a month when a system needs correction alongside conventional care. Cytomax capsules are taken 10 to 15 minutes before meals, one to two at a time, across the three-month run. Then you stop and let the tissue hold what it gained.
What the first weeks actually feel like
Peptides do not announce themselves. Nothing shifts on day two, and there is no stimulant edge to notice. Effects accumulate as cellular function normalizes, which is why the protocol is written in months and why courses are defined rather than open-ended. Anyone promising a next-day result is describing a different product.
Capsules or lingual drops: where the peptide lands
Both lines ship in 20- and 60-capsule packs and in a lingual form, liquid drops held under the tongue. No tablets, no sprays. The 20-count covers a short course or a first trial of an unfamiliar bioregulator; the 60-count carries a full month at the corrective dose, or a longer natural protocol without a reorder in the middle.
The lingual route matters mechanically. Peptides are proteins, and proteins meet enzymes in the stomach. Drops absorbed through the oral mucosa reach circulation before digestion breaks them apart, so the lingual format delivers more of the intact molecule per dose than any other oral option in these categories. Capsules stay the practical pick for long courses and for travel. A common pattern: drops for month one, capsules after.
Certified supply, and how to spot the copies
Where you buy weighs as much as what you buy. Much of what sells online as bioactive peptides is research-grade material from unregulated overseas suppliers (such as China), with no consumer documentation behind it.
Research-grade means what the label says: intended for laboratory work, sold without a verified human dose, without a purity guarantee for consumption, and outside the dietary supplement framework entirely. Nobody has checked identity, content, or contamination.
Before you buy peptide bioregulators from anyone, check five things:
- GMP manufacturing, confirmed at the facility rather than claimed by the storefront
- a Certificate of Analysis from an independent laboratory, tied to the batch you receive
- manufacturer registration with the FDA and food supplement notification in the EU
- ISO 9001 quality management on the production side
- batch documentation you can request before you order, not after
IPEPT products clear all five, and the formulations behind them carry a research record most supplements cannot match. Clinical studies of the cytomax and cytogen classes ran at the Medical Center of the St. Petersburg Institute of Bioregulation and Gerontology across more than a decade, covering 21 natural geroprotectors and 6 synthesized ones, with no side effects, contraindications, or dependence recorded in the published reports.
Your first three months, mapped
The peptide catalog pairs most natural peptides with a synthesized counterpart for the same system:
| Body system | Cytomax (natural) | Cytogen (synthesized) |
|---|---|---|
| Immunity | Vladonix | Crystagen |
| Vessels and circulation | Ventfort | Vesugen |
| Brain and nervous system | Cerluten | Pinealon |
| Joints and cartilage | Sigumir | Cartalax |
| Liver and digestion | Svetinorm | Ovagen |
| Bronchi and lungs | Taxorest | Chonluten |
The natural line runs wider than the synthesized one. Endoluten covers basic bioregulation, Glandokort the endocrine system, Visoluten the eyes, Pielotax the kidneys, Suprefort the pancreas, Gotratix the muscles. Where no cytogen counterpart exists, the cytomax stands on its own for the full course.
Month one runs the Cytogen matched to your system, lingual or capsule, to bring the tissue back online. Months two and three switch to the cytomax pair for a deeper, longer-lasting effect. The same sequence frames a peptide for healing support after injury or illness, and it frames anti-age protocols where the goal is health held across decades rather than a fast result. The best category of peptides is the one holding the right address for your tissue at the right point in the course.
Peptide therapy rewards the reader who does the homework before they order. The full peptide catalog sits at www.ipept.com, with target organ, composition, dose, and format on every product card. Read the category page for your system, compare Cytomax or Cytogen side by side, then order the pair that matches your priority.
The newsletter carries the protocol notes that never fit on a label. If necessary, request additional advice from experienced specialists directly on the website, who have worked with these products for over 10 years.
# References
1. Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23(Suppl 3):11-144. PMID: 12374906. https://pubmed.ncbi.nlm.nih.gov/12374906/
2. Khavinson VKh, Anisimov VN. Peptide regulation of aging: 35-year research experience. Bull Exp Biol Med. 2009;148(1):94-98. doi:10.1007/s10517-009-0650-8. PMID: 19902107. https://pubmed.ncbi.nlm.nih.gov/19902107/
3. Anisimov VN, Khavinson VKh. Peptide bioregulation of aging: results and prospects. Biogerontology. 2010;11(2):139-149. doi:10.1007/s10522-009-9249-8. https://link.springer.com/article/10.1007/s10522-009-9249-8
4. Vanyushin BF, Khavinson VKh. Short biologically active peptides as epigenetic modulators of gene activity. In: Epigenetics – A Different Way of Looking at Genetics. Springer; 2016:69-90. doi:10.1007/978-3-319-27186-6_5
5. Overcoming Oral Cavity Barriers for Peptide Delivery Using Advanced Pharmaceutical Techniques and Nano-Formulation Platforms. Biomedicines. 2025;13(11):2735. doi:10.3390/biomedicines13112735. PMID: 41301828. https://pubmed.ncbi.nlm.nih.gov/41301828/
6. U.S. Food and Drug Administration. 21 CFR Part 111: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111
7. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. OJ L 183, 12.7.2002. https://eur-lex.europa.eu/eli/dir/2002/46/oj/eng